There are 2867 resources available
687P - Differential expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: Analysis of concordance and factors impacting on variations
Presenter: Paolo Bossi
Session: Poster session 10
688P - Transcriptional profile changes in matched paired tumor samples after PARP inhibitor treatment in head and neck squamous cell carcinoma (HNSCC)
Presenter: Myrto Moutafi
Session: Poster session 10
689P - Effects of durvalumab-metformin on head and neck squamous cell carcinoma (HNSCC) as revealed by digital spatial profiling (DSP)
Presenter: Jacob Riordan
Session: Poster session 10
691P - DNA-based peripheral blood epigenetic immuno-profiling of recurrent/metastatic (R/M) squamous cell carcinoma of head and neck (SCCHN) treated with anti-programmed death (PD)-1 therapy
Presenter: Kartik Sehgal
Session: Poster session 10
693P - Impact of one-week hydration after each three-weekly concurrent cisplatin on the tolerance among locally advanced head and neck cancer patients receiving chemoradiotherapy
Presenter: Camelia Billard-Sandu
Session: Poster session 10
695P - Effectiveness and quality-of-life (QoL) data from real-world study (ProNiHN) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of head and neck (R/M SCCHN) treated with nivolumab (nivo) in France
Presenter: Christophe Le Tourneau
Session: Poster session 10
696P - Geriatric nutritional risk index as a prognostic factor in elderly patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with cisplatin
Presenter: Yu Fujiwara
Session: Poster session 10